Submandibular salivary proteases: Lack of a role in Anti-HIV activity

被引:20
作者
Kennedy, S
Davis, C
Abrams, WR
Billings, PC
Nagashunmugam, T
Friedman, H
Malamud, D [1 ]
机构
[1] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Dent Med, Dept Anat Histol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Infect Dis, Philadelphia, PA 19104 USA
关键词
saliva; HIV-1; proteases;
D O I
10.1177/00220345980770070601
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Whole human saliva contains a number of proteolytic enzymes, mostly derived from white blood cells and bacteria in the oral cavity. However, less information is available regarding proteases produced by salivary glands and present in salivary secretions. In the present study, we have analyzed submandibular saliva, collected without contaminating cells, and identified multiple proteolytic activities. These have been characterized in terms of their susceptibility to a series of protease inhibitors. The submandibular saliva proteases were shown to be sensitive to both serine and acidic protease inhibitors. We also used protease inhibitors to determine if salivary proteolytic activity was involved in the inhibition of HIV infectivity seen when the virus is incubated with human saliva. This anti-HIV activity has been reported to occur in whole saliva and in ductal saliva obtained from both the parotid and submandibular glands, with highest levels of activity present in the latter fluid. Protease inhibitors, at concentrations sufficient to block salivary proteolytic activity in an in vitro infectivity assay, did not block the anti-HIV effects of saliva, suggesting that the salivary proteases are not responsible for the inhibition of HIV-1 infectivity.
引用
收藏
页码:1515 / 1519
页数:5
相关论文
共 23 条
[1]   Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV [J].
Baba, TW ;
Trichel, AM ;
An, L ;
Liska, V ;
Martin, LN ;
MurpheyCorb, M ;
Ruprecht, RM .
SCIENCE, 1996, 272 (5267) :1486-1489
[2]  
BARR CE, 1992, J AM DENT ASSOC, V123, P36
[3]  
BARR CE, 1992, J AM DENT ASSOC, V123, P39
[4]   AGGREGATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HUMAN SALIVARY SECRETIONS [J].
BERGEY, EJ ;
CHO, MI ;
HAMMARSKJOLD, ML ;
REKOSH, D ;
LEVINE, MJ ;
BLUMBERG, BM ;
EPSTEIN, LG .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (3-4) :467-474
[5]  
BERGEY EJ, 1994, J ACQ IMMUN DEF SYND, V7, P995
[6]   A GROWTH-REGULATED PROTEASE ACTIVITY THAT IS INHIBITED BY THE ANTICARCINOGENIC BOWMAN-BIRK PROTEASE INHIBITOR [J].
BILLINGS, PC ;
HABRES, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3120-3124
[7]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[8]   SALIVARY INHIBITION OF HIV-1 INFECTIVITY - FUNCTIONAL-PROPERTIES AND DISTRIBUTION IN MEN, WOMEN, AND CHILDREN [J].
FOX, PC ;
WOLFF, A ;
YEH, CK ;
ATKINSON, JC ;
BAUM, BJ .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1989, 118 (06) :709-711
[9]   SALIVA INHIBITS HIV-1 INFECTIVITY [J].
FOX, PC ;
WOLFF, A ;
YEH, CK ;
ATKINSON, JC ;
BAUM, BJ .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1988, 116 (06) :635-637
[10]  
FULTZ PN, 1986, LANCET, V2, P1215